Evidence map›Paper›PMID 27384174›Full record

ArticleWorld journal of surgery2016

Selective Parathyroid Hormone Venous Sampling in Patients with Persistent or Recurrent Primary Hyperparathyroidism and Negative, Equivocal or Discordant Noninvasive Imaging.

Philip Y Sun, Scott M Thompson, James C Andrews, Robert A Wermers, Travis J McKenzie, Melanie L Richards, David R Farley, Geoffrey B Thompson

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. WillEndocrine · 2021
    Review
  12. Article
  13. Recurrent primary hyperparathyroidism: a diagnostic and management dilemma.Endocrinology, diabetes & metabolism case reports · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Philip Y SunMayo Medical School, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
Scott M ThompsonDepartment of Radiology, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
James C AndrewsDepartment of Radiology, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
Robert A WermersDivision of Diabetes, Endocrinology and Metabolism, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
Travis J McKenzieDepartment of Surgery, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
Melanie L RichardsDepartment of Surgery, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
David R FarleyDepartment of Surgery, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA.
Geoffrey B ThompsonDepartment of Surgery, College of Medicine, Mayo Clinic 200 1st St SW, Rochester, MN, 55905, USA. thompson.geoffrey@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with persistent (P-PHPT) or recurrent (R-PHPT) primary hyperparathyroidism, preoperative localization is important. Selective parathyroid hormone venous sampling (sPVS) is an invasive technique that can be used to regionalize and/or lateralize the source of PHPT when noninvasive imaging studies are nonlocalizing. The aim of the present study was to assess the role of sPVS in the preoperative evaluation of patients with P-PHPT or R-PHPT and negative, equivocal, or discordant noninvasive imaging localization.

methodsAfter IRB-approval a retrospective review of all patients with P-PHPT or R-PHPT and nonlocalizing noninvasive imaging that underwent sPVS from 2000 to 2014 was performed. The location of the source of PHPT at sPVS was predicted by a parathyroid hormone (PTH) gradient and compared to the surgical, pathology, and biochemical follow-up data as the gold standard. Sensitivity and positive predictive value (PPV) were calculated.

resultsOf 30 patients who underwent sPVS, 12 patients did not undergo surgical exploration due to negative or non-localizing PTH gradient (n = 8) or opted for medical management (n = 4). Of the 18 patients who underwent surgical exploration, 17 (94 %) had a positive PTH gradient and pathologic parathyroid tissue identified at surgery. Sensitivity and PPV of sPVS were 93 and 77 %, respectively, for all surgical cases, 86 and 60.0 % for cervical cases (n = 11), and 100 and 100 % for mediastinal cases (n = 7). Sixteen patients (89 %) were surgically cured.

conclusionsIn patients with P-PHPT or R-PHPT and nonlocalizing imaging studies, sPVS is a sensitive test for localizing the source of PHPT when a positive PTH gradient is present.

Indexed as

AdultAgedFemaleHumansHyperparathyroidism, PrimaryMaleMediastinumMiddle AgedNeckParathyroidectomyParathyroid HormonePhlebotomyPreoperative CareRecurrenceRetrospective StudiesSensitivity and SpecificityParathyroid Hormone

Identifiers

PMID27384174
OpenAlexW2460114502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.